Variable | OCD | LAD | p value |
---|---|---|---|
N (%) | 703 (52) | 640 (48) | – |
Preoperative | |||
 Age, mean (SD), years | 67 (10) | 68 (10) | 0.04 |
 Sex, males, n (%) | 528 (75) | 461 (72) | 0.24 |
 BMI, kg/m2, mean (SD) | 28 (5) | 27 (5) | 0.01 |
 ASA score, median (IQR) | 2 (2–3) | 3 (2–3) | 0.06 |
 Prior surgery, n (%) | 221 (31) | 209 (33) | 0.63 |
 NAC, n (%) | 139 (20) | 126 (20) | 0.97 |
Operative | |||
 Ileal conduit,n(%) | 503 (72) | 529 (83) | < 0.001 |
 Intracorporeal diversion, n (%) | 435 (76) | 347 (72) | 0.12 |
 Operative time, median (IQR), min | 371 (310–450) | 369 (310–442) | 0.80 |
 EBL, mean (SD), ml | 376 (339) | 444 (513) | 0.05 |
Perioperative | |||
 Hospital stay, median (IQR), days | 9 (7–13) | 9 (7–13) | 0.42 |
 ICU stay, median (IQR), days | 1 (0–1) | 1 (0–1) | 0.73 |
 Adjuvant treatment,n(%) | 26 (4) | 154 (24) | < 0.001 |
 30-d complications, n (%) | 224 (32) | 205 (32) | 0.95 |
 90-d complications, n (%) | 261 (37) | 249 (39) | 0.50 |
 30-d high-grade complications, n (%) | 63 (9) | 72 (11) | 0.16 |
 90-d high-grade complications, n (%) | 74 (11) | 88 (14) | 0.07 |
 30-d readmission, n (%) | 48 (7) | 50 (8) | 0.49 |
 90-d readmission, n (%) | 85 (12) | 91 (14) | 0.25 |
 30-d mortality, n (%) | 4 (0.6) | 7 (1) | 0.29 |
 90-d mortality,n(%) | 12 (1.9) | 33 (6) | < 0.001 |
Pathologic | |||
 LNY, mean (SD) | 18 (11) | 18 (11) | 0.86 |
 Positive LN, n (%) | 0 (0) | 301 (47) | NA |
 Pathologic T stage > 2 | 0 (0) | 544 (86) | NA |
 PSM,n(%) | 16 (2) | 89 (14) | < 0.001 |
 Any recurrence,n(%) | 73 (10) | 252 (39) | < 0.001 |
 Local recurrence,n(%) | 31 (4) | 123 (19) | < 0.001 |
 Distant recurrence (n) | 56 (8) | 198 (31) | < 0.001 |
 Median time to any recurrence (months) | 12 (6-21) | 6 (3-11) | < 0.001 |
 Non-TCC histology, n (%) | 163 (30) | 171 (30) | 0.76 |
QCS domains | |||
 Preoperative | 139 (20) | 126 (20) | 0.97 |
 Operative | 359 (51) | 318 (50) | 0.61 |
 Postoperative | 603 (86) | 529 (83) | 0.12 |
Pathologic | 266 (38) | 209 (33) | 0.05 |